124 related articles for article (PubMed ID: 38276760)
1. Triterpenoidal Saponins from the Leaves of
Kim JY; Kim TY; Son SR; Kim SY; Kwon J; Kwon HC; Lee CJ; Jang DS
Plants (Basel); 2024 Jan; 13(2):. PubMed ID: 38276760
[TBL] [Abstract][Full Text] [Related]
2. Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation.
Kim TY; Kim JY; Kwon HC; Jeon S; Lee SJ; Jung H; Kim S; Jang DS; Lee CJ
Antiviral Res; 2022 Dec; 208():105428. PubMed ID: 36252824
[TBL] [Abstract][Full Text] [Related]
3. Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern.
Kim TY; Jeon S; Ko M; Du YE; Son SR; Jang DS; Kim S; Lee CJ
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0120122. PubMed ID: 36374087
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship study of saponin-based membrane fusion inhibitors against SARS-CoV-2.
Jang Y; Young Kim T; Jeon S; Lim H; Lee J; Kim S; Justin Lee C; Han S
Bioorg Chem; 2022 Oct; 127():105985. PubMed ID: 35809512
[TBL] [Abstract][Full Text] [Related]
5. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
6. The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants.
Tietjen I; Cassel J; Register ET; Zhou XY; Messick TE; Keeney F; Lu LD; Beattie KD; Rali T; Tebas P; Ertl HCJ; Salvino JM; Davis RA; Montaner LJ
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0077221. PubMed ID: 34543092
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
[TBL] [Abstract][Full Text] [Related]
8. Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19.
Bojadzic D; Alcazar O; Buchwald P
Front Pharmacol; 2020; 11():600372. PubMed ID: 33519460
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern.
Vanhulle E; D'huys T; Provinciael B; Stroobants J; Camps A; Noppen S; Schols D; Van Damme EJM; Maes P; Stevaert A; Vermeire K
Front Cell Infect Microbiol; 2022; 12():989534. PubMed ID: 36111239
[No Abstract] [Full Text] [Related]
10. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
11. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors.
Palla SR; Li CW; Chao TL; Lo HV; Liu JJ; Pan MY; Chiu YT; Lin WC; Hu CW; Yang CM; Chen YY; Fang JT; Lin SW; Lin YT; Lin HC; Kuo CJ; Wang LH; Chang SY; Liang PH
Antiviral Res; 2023 Nov; 219():105735. PubMed ID: 37858764
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structural optimization of 3-O-β-Chacotriosyl betulonic acid saponins as potent fusion inhibitors of Omicron virus infections.
Liu M; Wang J; Wan X; Li B; Guan M; Ning X; Hu X; Li S; Liu S; Song G
Bioorg Chem; 2023 Feb; 131():106316. PubMed ID: 36508939
[TBL] [Abstract][Full Text] [Related]
14. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.
Ho HPT; Vo DNK; Lin TY; Hung JN; Chiu YH; Tsai MH
Biomed Pharmacother; 2022 Nov; 155():113766. PubMed ID: 36271550
[TBL] [Abstract][Full Text] [Related]
15. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
16. PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding.
Vanderlinden E; Boonen A; Noppen S; Schoofs G; Imbrechts M; Geukens N; Snoeck R; Stevaert A; Naesens L; Andrei G; Schols D
Antiviral Res; 2023 Sep; 217():105700. PubMed ID: 37562608
[TBL] [Abstract][Full Text] [Related]
17. Prevention of SARS-CoV-2 cell entry: insight from
Gyebi GA; Adegunloye AP; Ibrahim IM; Ogunyemi OM; Afolabi SO; Ogunro OB
J Biomol Struct Dyn; 2022 Mar; 40(5):2121-2145. PubMed ID: 33089728
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
[TBL] [Abstract][Full Text] [Related]
19. A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).
Zeng MS; Yu WD; Wang HX; Liu JY; Xu PP
Int J Biol Macromol; 2021 Jul; 183():2248-2261. PubMed ID: 34111482
[TBL] [Abstract][Full Text] [Related]
20. An Autophagy Inducing Triterpene Saponin Derived from
Kwon J; Ko K; Zhang L; Zhao D; Yang HO; Kwon HC
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]